Literature DB >> 18974445

[Osteoarthritis of the knee joint as a cause of musculoskeletal ambulation disability symptom complex (MADS)].

Tadashi Hayami1.   

Abstract

Osteoarthritis is considered as a chronic disease of the whole joint, including articular cartilage, meniscus, ligament, and peri-articular muscle that may result from multiple pathophysiological mechanisms. Osteoarthritis is a painful and disabling disease that affects millions of patients. Its aetiology is largely unknown, but is most likely multi-factorial. No proven disease-modifying therapy exists for osteoarthritis and current treatment options for chronic osteoarthritic pain are insufficient, but new pharmacotherapeutic options are emerging. Surgical treatment, such as high tibial osteotomy and total knee arthroplasty are chosen for the patient who have severe pain and disabled patient. In recent 10 years, operation cases are increasing in number, but these procedure still have many issues to resolve. Osteoarthritis of the knee joint is one of a major cause of Musculoskeletal Ambulation Disability Symptom Complex (MADS) , and it is important to improve conservative and surgical treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18974445     DOI: CliCa081115741580

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  11 in total

Review 1.  Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I.

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2011

2.  Postoperative pain monitor after total knee replacement.

Authors:  Angela Notarnicola; Lorenzo Moretti; Silvio Tafuri; Angelo Vacca; Gioacchino Marella; Biagio Moretti
Journal:  Musculoskelet Surg       Date:  2011-03-09

3.  Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions.

Authors:  Elizaveta Kon; Roberto Buda; Giuseppe Filardo; Alessandro Di Martino; Antonio Timoncini; Annarita Cenacchi; Pier Maria Fornasari; Sandro Giannini; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-17       Impact factor: 4.342

4.  Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis.

Authors:  Giuseppe Filardo; Elizaveta Kon; Roberto Buda; Antonio Timoncini; Alessandro Di Martino; Annarita Cenacchi; Pier Maria Fornasari; Sandro Giannini; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-08-26       Impact factor: 4.342

5.  Expression of the deubiquitinase cylindromatosis in articular cartilage and subchondral bone is associated with the severity of knee osteoarthritis.

Authors:  Liu Hong; Yu Shanjiang; Wang Qian; Li Chunguo; Zhou Fei; Yu Jinming; Gao Jiyou; Li Na; Li Yang; Du Feng
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

6.  Motor Function Relating to the Accuracy of Self-Overestimation Error in Community-Dwelling Older Adults.

Authors:  Tsubasa Kawasaki; Ryosuke Tozawa
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

7.  Recognizing the Role of the Posterolateral Corner in Patients Undergoing Total Knee Arthroplasty for Fixed Varus Deformity.

Authors:  Ashok Rajgopal; Sumit Kumar; Kalpana Aggarwal
Journal:  Orthop Res Rev       Date:  2021-10-08

8.  Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture.

Authors:  Ichiro Yoshii; Tatsumi Chijiwa; Naoya Sawada; Shohei Kokei
Journal:  Osteoporos Sarcopenia       Date:  2021-09-17

9.  Use of allogeneic freeze-dried conditioned serum for the prevention of degradation in cartilage exposed to IL-1ß.

Authors:  Livia Camargo Garbin; C Wayne McIlwraith; David D Frisbie
Journal:  BMC Vet Res       Date:  2022-07-11       Impact factor: 2.792

10.  Evaluation of allogeneic freeze-dried platelet lysate in cartilage exposed to interleukin 1-β in vitro.

Authors:  Livia Camargo Garbin; C Wayne McIlwraith; David D Frisbie
Journal:  BMC Vet Res       Date:  2019-11-01       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.